Glenmark Strikes $1.1 Billion Deal for Next-Gen Cancer Drug
On Wednesday, Glenmark Pharmaceuticals announced a significant licensing agreement with Hengrui Pharma. Under the …
India News
KEC International’s Shares Soar 8% on New ₹3,243 Crore Order Win
After securing new orders worth ₹3,243 crore, KEC International’s shares soared nearly 8% on …
The Premature Petition: Why You Can’t Challenge a Show Cause Notice
Writ petitions challenging a Show Cause Notice (SCN) are generally considered premature because an …
Orissa High Court Stays ₹231 Crore GST Demand Against Vedanta
Orissa High Court Stays ₹231 Crore GST Demand Against Vedanta, Citing Constitutional Challenge to …
Trump and Modi Signal Thaw in Trade Talks Amid Lingering Tariffs
US President Donald Trump recently announced that the U.S. and India are continuing trade …
